Table 2. GO-Terms enrichment analysis.

Gene enrichment analysis in 2cPE treated primary B-CLL cells
GO-Term	Count	%	p Value	Benjamini	FDR	Fold Enr
GO:0006986~response to unfolded protein	13	8,33	1,66E-12	2,67E-09	2,78E-09	19,82
GO:0051789~response to protein stimulus	13	8,33	3,90E-07	1,96E-07	4,08E-07	13,15
GO:0050865~regulation of cell activation	14	8,97	7,16E-09	3,84E-06	1,20E-05	8,66
GO:0010033~response to organic substance	25	16,02	3,11E-08	1,25E-05	5,21E-05	3,75
GO:0006457~protein folding	13	8,33	7,73E-08	1,75E-05	0,00013	7,94
GO:0042981~regulation of apoptosis	25	16,02	2,38E-07	4,80E-05	0,0004	3,37
Gene enrichment analysis in Bortezomib treated primary B-CLL cells
GO-Term	Count	%	p Value	Benjamini	FDR	Fold Enr
GO:0000502~proteasome complex	14	15,73	4,31E-18	5,26E-16	4,97E-15	42,52
GO:0051351~positive regulation of ligase activity	15	16,85	1,35E-18	1,16E-15	2,09E-15	37,56
GO:0043161~proteasomal protein catabolic process	15	16,85	1,91E-16	1,91E-14	3,44E-13	26,88